Efficacy of Music on Reduction of Sedative Drugs in Mechanically Ventilated Intensive Care Unit Patients
NCT ID: NCT00880035
Last Updated: 2009-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
50 participants
INTERVENTIONAL
2008-12-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Impact on sedative drug consumption.
2. Alteration of stress neuropeptide blood concentrations.
Population: mechanically-ventilated ICU patients
The investigators hypothesize the music will decrease the need of sedative drugs and reduce the concentration of neuropeptides in circulation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medical Use of Song In Critical Care (MUSIC)
NCT01763736
Music Use for Sedation In Critically Ill Children
NCT03497559
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
NCT03642002
The Impact of Receptive Music Therapy in the ICU
NCT03931733
The Effect of Music on Procedural Distress During Mobilization in Intensive Care Unit Patients: A Randomized Controlled Trial
NCT06174662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There will be two groups both of exposed to music and placebo (headphones without music). The study will be simple blind.
Sedation scale will be followed regularly. Vitals signs and adjustment of sedation will be recorded by the nurse on the ward. Blood test will be taken before and after placement of headphones in the morning. We will measure IL-6, cortisol, copeptin, prolactin, CRP.
We will analyse the total reduction dose of sedation and analgesia on a daily basis. We will consider a fall of 20% of medication to be significative.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Group A: day 1 = music, day 2 = washout, day 3 = headphone without music
MP3 music program listening
3 days with two 1 hour periods of headset music listening (1 day on, 1 day wash-out, 1 day off)
Group B
Group B: day 1 = headphone without music, day 2 = washout, day 3 = music
MP3 music program listening
3 days with two 1 hour periods of headset music listening (1 day on, 1 day wash-out, 1 day off)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MP3 music program listening
3 days with two 1 hour periods of headset music listening (1 day on, 1 day wash-out, 1 day off)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* expected time of mechanical ventilation of more than 72 hours
* sedation needs for a scale of Sedation-Agitation Scale (SAS) more than 1
Exclusion Criteria
* pregnancy
* needs of vasopressin
* needs of curarisation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre de Recherche Clinique CHUS
UNKNOWN
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CRC-CHUS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Lesur, MD
Role: PRINCIPAL_INVESTIGATOR
CHUS and Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUS
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRC-PAFI-09
Identifier Type: -
Identifier Source: secondary_id
08-105-R2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.